Analgesic Efficacy of Ultrasound-guided External Oblique Intercostal Plane Block Versus Posterior Transversus Abdominis Plane Block in Patients Undergoing Open Nephrectomy
Launched by CAIRO UNIVERSITY · Mar 22, 2025
Trial Information
Current as of April 30, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different techniques for managing pain after surgery to remove a kidney, called open nephrectomy. Many patients experience significant pain after this procedure, which can lead to complications and longer hospital stays. The trial aims to compare two methods of numbing the area to see which one works better: the external oblique intercostal plane block (EOIPB) and the posterior transversus abdominis plane block (TAP block). These techniques use ultrasound to guide the injection, helping to reduce pain and improve recovery.
To participate in this study, you must be between 18 and 65 years old, diagnosed with renal cancer, and scheduled for the surgery. Certain health conditions, like serious liver or heart issues, or if you regularly use opioids, may prevent you from joining. If you decide to participate, you can expect to receive one of the pain management techniques during your surgery, and the researchers will observe how well it helps with your pain after the operation. This study could lead to better pain management options for patients undergoing kidney surgery in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients whom diagnosed as having renal carcinoma and scheduled for open nephrectomy under general anesthesia.
- • ASA class II- III.
- • Age ≥ 18 and ≤ 65 years.
- • Body mass index (BMI) less than 40kg/m2.
- Exclusion Criteria:
- • 1. Patient refusal. 2. Hepatic and renal insufficiency. 3. Unstable cardiovascular or pulmonary disease. 4. History of psychiatric and cognitive disorders. 5. Patients with known sensitivity or contraindications to the drug used. 6. Patients on regular opioid consumption.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Maadi, Cairo, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported